UPC_APP_33484/2024

PROSTHETIC HEART VALVE

Prozessuale & UnteranträgeAkteneinsicht (RoP262)Paris CDGenericCase Closed

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Name not displayed for GDPR reasons. Represented by Erik KRAHBICHLER

Vertreter:

Beklagte

Meril Life Science Private Limited(Meril Group)(Edwards Lifesciences Group)
Meril GmbH(Meril Group)(Edwards Lifesciences Group)
Meril Italy S.r.l.(Meril Group)(Edwards Lifesciences Group)
Edwards Lifesciences Corporation(Meril Group)(Edwards Lifesciences Group)

Vertreter: Emmanuel Larere (Cabinet Gide Loyrette Nouel AARPI); Jean-Hyacinthe de Mitry (Cabinet Gide Loyrette Nouel AARPI); Jonathan Stafford (Marks & Clerk LLP); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Bryce Matthewson (Powell Gilbert LLP); Bernhard Thum (Thum & Partner); Jonas Weickert (Thum & Partner)

Richter

Französische Kammer — Einzelrichter anonymisiert.

Panel member (anonymized)
Panel member (anonymized)
Panel member (anonymized)

Patente

EP4151181
EP 4 151 181

CPC-Codes: A61F2220/0075, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2412, A61F2250/0097, A61F2/2433, A61F2250/0036

Sektor: Pharmaceutical & Medical

Ausgang

Nur prozessual

Eingereicht: 5. Juni 2024

Erste Entscheidung: 23. Sept. 2024

Sprache: English

Im UPC-Register öffnen